Skip to Main content Skip to Navigation
Journal articles

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Francisco Alves 1 Inês F Antunes 2 Emiliano Cazzola 3 Frederik Cleeren 4 Bart Cornelissen 2 Antonia Denkova 5 Jonathan Engle 6 Alain Faivre-Chauvet 7 Nic Gillings 8 Jeroen J M A Hendrikx 9 Amir R Jalilian 10 Nicholas P van Der Meulen 11 Renata Mikolajczak 12 Oliver C Neels 13 Maroor R A Pillai 14 Raymond Reilly 15 Sietske Rubow 16 Yann Seimbille 17 Sarah Spreckelmeyer 18 Wiktor Szymanski 19 Carlotta Taddei 20 
1 UC - University of Coimbra [Portugal]
2 UMCG - University Medical Center Groningen [Groningen]
3 IRCCS Sacro Cuore Don Calabria Hospital [Vérone, Italie]
4 KU Leuven - Catholic University of Leuven - Katholieke Universiteit Leuven
5 TU Delft - Technische Universiteit Delft
6 University of Wisconsin-Madison
7 CRCINA-ÉQUIPE 13 - Nuclear Oncology
CRCINA - Centre de Recherche en Cancérologie et Immunologie Nantes-Angers
8 Rigshospitalet [Copenhagen]
9 NKI - Netherlands Cancer Institute
10 IAEA - International Atomic Energy Agency [Vienna]
11 PSI - Paul Scherrer Institute
12 POLATOM - Radioisotope Centre POLATOM [Otwock, Pologne]
13 HZDR - Helmholtz-Zentrum Dresden-Rossendorf
14 Molecular Group of Companies - DDRC SRL Diagnostics [Kerala, India]
15 University of Toronto
16 Stellenbosch University
17 Erasmus MC - Erasmus University Medical Center [Rotterdam]
18 Charité - UniversitätsMedizin = Charité - University Hospital [Berlin]
19 University of Groningen [Groningen]
20 NIH - National Institutes of Health [Bethesda]
Abstract : Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results: This commentary of highlights has resulted in 21 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Also the first contribution in relation to MRI-agents is included. Conclusions: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.
Keywords : Radiopharmacy Radiochemistry Highlight selection
Document type :
Journal articles
Complete list of metadata
https://www.hal.inserm.fr/inserm-03338402
Contributor : Elizabeth Bernardo Connect in order to contact the contributor
Submitted on : Wednesday, September 8, 2021 - 3:49:29 PM
Last modification on : Tuesday, May 3, 2022 - 3:14:05 PM
Long-term archiving on: : Friday, December 10, 2021 - 9:55:18 AM

File

Vignette du document
FaivreChauvet2021Eq13.pdf
Publication funded by an institution

Identifiers

Collections

INSERM | UNIV-NANTES | CNRS | UNIV-ANGERS | CRCINA | NANTES-UNIVERSITE

Citation

Francisco Alves, Inês F Antunes, Emiliano Cazzola, Frederik Cleeren, Bart Cornelissen, et al.. Highlight selection of radiochemistry and radiopharmacy developments by editorial board. European Association of Nuclear Medicine, issuing body - EJNMMI radiopharmacy and chemistry, London : Springer Open, [2016]-, 2021, 6, pp.31. ⟨10.1186/s41181-021-00146-9⟩. ⟨inserm-03338402⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

39

Files downloads

31